Tien, A., Li, J., Bao, X., DeRogatis, A., Fujita, Y., Pennington-Krygier, C., . . . Sanai, N. (2019). OS8.1 A phase 0/2 clinical trial of a CDK4/6 inhibitor in aggressive meningioma patients. Neuro Oncol.
Stile di citazione ChicagoTien, A., J. Li, X. Bao, A. DeRogatis, Y. Fujita, C. Pennington-Krygier, S. Kim, S. Mehta, e N. Sanai. "OS8.1 A Phase 0/2 Clinical Trial of a CDK4/6 Inhibitor in Aggressive Meningioma Patients." Neuro Oncol 2019.
Citazione MLATien, A., et al. "OS8.1 A Phase 0/2 Clinical Trial of a CDK4/6 Inhibitor in Aggressive Meningioma Patients." Neuro Oncol 2019.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.